These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1507198)

  • 1. Mapping the binding site of tissue kallikrein: preparation and testing of all possible substrate analog inhibitors homologous with the sequence of kininogen between Ser386 and Gln392.
    Deshpande MS; Burton J
    J Med Chem; 1992 Aug; 35(17):3094-102. PubMed ID: 1507198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic approach for determining minimum inhibitory sequence and contribution of individual residues in binding of kininogen fragments to tissue kallikrein.
    Deshpande MS; Burton J
    Agents Actions Suppl; 1992; 38 ( Pt 1)():210-6. PubMed ID: 1466273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
    Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of secondary interactions on the kinetics of peptide and peptide ester hydrolysis by tissue kallikrein and trypsin.
    Fiedler F
    Eur J Biochem; 1987 Mar; 163(2):303-12. PubMed ID: 3643848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate specificity of porcine pancreatic kallikrein.
    Fiedler F; Leysath G
    Adv Exp Med Biol; 1979; 120A():261-71. PubMed ID: 495315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
    McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
    Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo inhibition of tissue kallikreins by kininogen sequence analogue peptides.
    Okunishi H; Spragg J; Burton J; Toda N
    Adv Exp Med Biol; 1989; 247B():23-8. PubMed ID: 2481944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
    El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
    Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of substrate analogue inhibitors of human urinary kallikrein.
    Okunishi H; Burton J; Spragg J
    Hypertension; 1985; 7(3 Pt 2):I72-5. PubMed ID: 3846567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromogenic and fluorogenic glycosylated and acetylglycosylated peptides as substrates for serine, thiol and aspartyl proteases.
    Juliano MA; Filira F; Gobbo M; Rocchi R; Del Nery E; Juliano L
    J Pept Res; 1999 Feb; 53(2):109-19. PubMed ID: 10195448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
    Page JD; You JL; Harris RB; Colman RW
    Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of the segment (11-23) located in the first tandem repeat of plasma kallikrein: comparative binding studies of this and another segment (328-343) to high-molecular-mass kininogen.
    Basak A; Yuan XW; Harris R; Seidah NG; Chrétien M
    J Chromatogr; 1993 Jun; 615(2):251-64. PubMed ID: 8335703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of human and porcine tissue kallikrein substrate specificities.
    Del Nery E; Chagas JR; Juliano MA; Juliano L; Prado ES
    Immunopharmacology; 1999 Dec; 45(1-3):151-7. PubMed ID: 10615005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo assay of specific kallikrein inhibitors.
    Okunishi H; Spragg J; Burton J
    Agents Actions Suppl; 1987; 22():381-90. PubMed ID: 3481213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High molecular weight kininogen peptides inhibit the formation of kallikrein on endothelial cell surfaces and subsequent urokinase-dependent plasmin formation.
    Lin Y; Harris RB; Yan W; McCrae KR; Zhang H; Colman RW
    Blood; 1997 Jul; 90(2):690-7. PubMed ID: 9226169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of kallikrein-like serine proteinases from rat submandibular glands.
    Bedi GS
    Prep Biochem Biotechnol; 1996 May; 26(2):85-104. PubMed ID: 8784920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of glandular kallikrein by peptide analog antagonists of bradykinin.
    Spragg J; Vavrek RJ; Stewart JM
    Peptides; 1988; 9(1):203-6. PubMed ID: 3362744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human and rat tissue kallikreins by peptide analog antagonists of bradykinin.
    Spragg J; Vavrek RJ; Stewart JM
    Adv Exp Med Biol; 1989; 247B():277-81. PubMed ID: 2610073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin specificity. Requirement for apolar amino acids adjacent to the thrombin cleavage site of polypeptide substrate.
    Chang JY
    Eur J Biochem; 1985 Sep; 151(2):217-24. PubMed ID: 2863141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.